Mapping the genetic features of T-ALL cases through simplified NGS approach

Clin Immunol. 2022 Dec:245:109151. doi: 10.1016/j.clim.2022.109151. Epub 2022 Oct 19.

Abstract

Background: Despite the irruption of massive sequencing technologies in clinical routine, the genetic diagnosis of T-cell acute lymphoblastic leukemia (T-ALL) continues to be based on traditional techniques. The integration of old and new technologies with diagnostic and prognostic purposes represents a major challenge.

Methods: A High-Throughput Sequencing (HTS) approach was applied to analyze the genetic landscape of two patients diagnosed with T-ALL and one early T cell precursor acute leukemia. Orthogonal standard techniques were used to confirm the findings of NGS analysis.

Results: By using a single test, a complete genetic map including 2 previously unreported missense mutations in BCL11B gene are reported. Cooperating oncogenic lesions including CDKN2A/B deletions, SIL-TAL1 rearrangement and FLT3 amplification were also captured by using a single test.

Conclusions: HTS is a useful approach that allows simultaneously analyzing mutations, CNVs and the clonal repertoire in T-ALL patients. This approach may simplify the genetic assessment of ALL.

Keywords: BCL11B; CNVs; NGS; T-ALL; VDJ-rearrangement.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Copy Number Variations
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Mutation / genetics
  • Oncogene Proteins, Fusion / genetics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / pathology
  • Prognosis

Substances

  • SIL-TAL1 fusion protein, human
  • Oncogene Proteins, Fusion